Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer. Shore ND, Luz MA, De Giorgi U, Gleave M, et al. N Engl J Med 2025 Oct 19. doi: 10.1056/NEJMoa2510310.

Read + Share

Amedeo Smart

Independent Medical Education

Shore ND, Luz MA, De Giorgi U, Gleave M, et al. Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer. N Engl J Med 2025 Oct 19. doi: 10.1056/NEJMoa2510310.
PMID: 41124201